首页> 外国专利> TREATMENT OF CUTANEOUS ADVERSE EFFECTS CAUSED BY ONCOLOGICAL THERAPY WITH TOPICAL TAPINAROF COMPOSITIONS

TREATMENT OF CUTANEOUS ADVERSE EFFECTS CAUSED BY ONCOLOGICAL THERAPY WITH TOPICAL TAPINAROF COMPOSITIONS

机译:用局部木薯组合物肿瘤治疗引起的皮肤不良影响

摘要

Provided herein is a topical composition comprising tapinarof and methods of treatment of cutaneous adverse effects caused by oncological therapy with the tapinarof composition. The tapinarof compositions of this invention are useful for the treatment, prevention or amelioration of cutaneous and/or mucosal adverse effect caused by oncological therapy selected from chemotherapy, immunotherapy, radiation therapy, targeted therapy, hormone therapy and stem cell transplant therapy.
机译:本文提供了一种局部组合物,其包含木薯酰胺和治疗皮肤不良反应的方法,由肿瘤组合物肿瘤疗法引起。本发明的Tapinarof组合物可用于治疗,预防或改善由选自化疗,免疫疗法,放射治疗,靶向治疗,激素治疗和干细胞移植治疗的肿瘤治疗引起的皮肤和/或粘膜不良影响。

著录项

  • 公开/公告号WO2021059283A1

    专利类型

  • 公开/公告日2021-04-01

    原文格式PDF

  • 申请/专利权人 SOL-GEL TECHNOLOGIES LTD.;

    申请/专利号WO2020IL51053

  • 发明设计人 ARKIN MOSHE;ZIGHELBOIM MARCEL;

    申请日2020-09-24

  • 分类号A61K31/05;A61K9;A61K9/06;A61K9/107;A61K47/44;A61P17;A61P17/16;

  • 国家 IL

  • 入库时间 2022-08-24 18:03:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号